• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Datatrak Looks for Strategic Alternatives

Datatrak Looks for Strategic Alternatives

July 30, 2008
CenterWatch Staff

Cleveland-based Datatrak International, a struggling electronic data capture (EDC) vendor, has retained Healthcare Growth Partners (HGP) as a strategic and financial advisor to assist its Board of Directors in evaluating a variety of potential opportunities directed at maximizing shareholder value.

These potential opportunities may include, but are not limited to, a sale, merger or other business combination of the company; strategic partnerships or alliances; or the raising of additional capital, should the company determine it is in the best interest of its shareholders to continue as a stand alone entity. HGP focuses exclusively on healthcare technology and related service-based organizations, providing strategic, operational and transaction advisory services to small and mid-sized healthcare companies.

“Over the past year we have focused on stabilizing our business through the optimization of our expense levels and staffing, while simultaneously continuing to advance our technology platform as we position our company to capitalize on the advantages of our unique single user interface and database architecture,” said Jeffrey Green, chief executive officer of Datatrak International. “We believe the maturation of this industry towards a single platform approach will eventually be realized because this creates optimum efficiencies for clinical trial sponsors and contract research organizations.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing